MedTrace Logo

Testosterone for Men With Insulin Treated Type 2 Diabetes

NCT00349362 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-03-30

No results posted yet for this study

Summary

The purpose of this study is to test the effect of testosterone treatment on glycaemic control, arterial stiffness and IMT in hypogonadal men with type 2 diabetes treated with insulin.

Conditions

Interventions

DRUG

Testosterone

Sustanon- 200mg intramuscular testosterone

DRUG

0.9% saline

Saline intramuscular injection every two weeks

Sponsors & Collaborators

  • Barnsley Hospital

    lead OTHER

Principal Investigators

  • Hugh Jones, BSc MD FRCP · Barnsley Hospital NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00349362 on ClinicalTrials.gov